Get the app!
Back to Trades

Kyme Pierre

Chief Business OfficerCIK 0002028892

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 2 filings between 2026, Kyme Pierre, Chief Business Officer, has disclosed $2.1M in transactions — all concentrated in Armata Pharmaceuticals, Inc. (ARMP). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Mar 17ARMP
Armata Pharmaceuticals, Inc.
Kyme PierreChief Business OfficerTax withheld$10.9K
Mar 11ARMP
Armata Pharmaceuticals, Inc.
Kyme PierreChief Business OfficerAward$2.1M

2 filings